New drug gets FDA approval for the treatment of common genetic disease in young boys

A new drug developed by professors from the School of Pharmacy and Pharmaceutical Sciences at Binghamton University has received Food and Drug Administration (FDA) approval for the treatment of patients with Duchenne muscular dystrophy (DMD), a common genetic disease that mostly affects young boys.

Oktoberfest Doctor: Not the Wurst Job You Could Have

Welcome to “Medical Mavericks,” a new series from MedPage Today featuring interviews with healthcare professionals working in unconventional fields of health and medicine. To kick

September 29, 2023

Pfizer to invest $1B in China over next five years — reports

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 8, 2024

Q&A: Penumbra CEO Adam Elsesser says new devices will drive changes in clot treatment

Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. With the launch of two new products,

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.